» Articles » PMID: 16234130

The Relationship Between Take-away Methadone Policies and Methadone Diversion

Overview
Specialty Psychiatry
Date 2005 Oct 20
PMID 16234130
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The development of policies in relation to unsupervised doses of methadone (take-away doses) should be based upon the best available evidence. There are both risks and benefits associated with take-away doses. This study aimed to explore the relationship between take-away policies and one measure of harm: methadone injection rates. Six different states in Australia were compared in relation to their methadone take-away policy and rates of methadone injection within their population of injecting drug users. At a simplistic level, those states with restrictive and less flexible take-away policies tended to have the lowest reported prevalence of methadone injection. However, this does not fully explain variability in methadone injecting. There were also considerable differences between those states with similar take-away policies. Variables which appear to impact upon methadone injecting rates include: take-away policies, drug preference, drug availability, treatment availability and degree of treatment penetration. Consideration of the benefits, rather than merely the harms, of various take-away policy options may provide an evidence-based platform for take-away policy development.

Citing Articles

Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis.

Qian G, Humphreys K, Goldhaber-Fiebert J, Brandeau M Drug Alcohol Depend. 2024; 256:111112.

PMID: 38335797 PMC: 10940194. DOI: 10.1016/j.drugalcdep.2024.111112.


The impact of COVID-19 on alcohol and other drug nurses' provision of care: A qualitative descriptive study.

Searby A, Burr D J Clin Nurs. 2021; 30(11-12):1730-1741.

PMID: 33656227 PMC: 8014781. DOI: 10.1111/jocn.15732.


Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California.

Zhao J, Kral A, Wenger L, Bluthenthal R Subst Use Misuse. 2019; 55(3):377-386.

PMID: 31608746 PMC: 7002277. DOI: 10.1080/10826084.2019.1673420.


Supervised dosing with a long-acting opioid medication in the management of opioid dependence.

Saulle R, Vecchi S, Gowing L Cochrane Database Syst Rev. 2017; 4:CD011983.

PMID: 28447766 PMC: 6478186. DOI: 10.1002/14651858.CD011983.pub2.


Take home maintenance medication in opiate dependence.

Gutwinski S, Bald L, Heinz A, Muller C, Schmidt A, Wiers C Dtsch Arztebl Int. 2013; 110(23-24):405-12.

PMID: 23837085 PMC: 3702025. DOI: 10.3238/arztebl.2013.0405.